Viral safety of plasma-derived medicinal products with respect to hepatitis E virus

  • Email
  • Help
Current version

Reflection paper

Reference numberEMA/CHMP/BWP/723009/2014
Published27/06/2016
KeywordsHepatitis E virus, plasma-derived products, blood infectivity
DescriptionThis document addresses the viral safety of plasma-derived medicinal products with respect to hepatitis E virus. It discusses HEV reduction by specific manufacturing steps and risk assessment for these products.


Document history

First version

Current version

Reflection paper


Overview of comments


Draft reflection paper


Concept paper 

Published: 27/06/2016


Published: 27/06/2016


Published: 01/07/2015


Published: 24/07/2008


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more